Journal article

+ 1 other files

Absorb bioresorbable scaffold versus xience metallic stent for prevention of restenosis following percutaneous coronary intervention in patients at high risk of restenosis: rationale and design of the COMPARE ABSORB trial

  • Chang, Chun Chin Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands - Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taiwan
  • Onuma, Yoshinobu Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands - Cardialysis Clinical Trials Management and Core Laboratories, Rotterdam, the Netherlands
  • Achenbach, Stephan Department of Cardiology, Universitätsklinikum Erlangen, Germany
  • Barbato, Emanuele Cardiovascular Research Center OLV Hospital, Aalst, Belgium
  • Chevalier, Bernard Ramsay Générale de Santé, ICPS, Hôpital Jacques Cartier, Massy, France
  • Cook, Stéphane Department of Cardiology, Hospital and University Fribourg, Switzerland
  • Dudek, Dariusz 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
  • Escaned, Javier Hospital Clinico San Carlos IDISSC, Complutense University, Madrid, Spain
  • Gori, Tommaso Center of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz and DZHK Standort Rhein-Main, Mainz, Germany
  • Kočka, Viktor Third Faculty of Medicine, Charles University and University Hospital Královske Vinohrady, Prague, Czech Republic
  • Tarantini, Giuseppe Interventional Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Italy
  • E.J.West, Nick Department of Interventional Cardiology, Royal Papworth Hospital, UK
  • Morice, Marie-Claude Ramsay Générale de Santé, Hopital Privé Jacques Cartier, Massy, France
  • G.P.Tijssen, Jan Amsterdam UMC, University of Amsterdam, the Netherlands
  • Geuns, Robert-Janvan Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands - Cardiology Department, Radboud UMC, Nijmegen, the Netherlands
  • C.Smits, Pieter Cardiology Department, Maasstad Hospital, Rotterdam, the Netherlands
Show more…
    2019
Published in:
  • Cardiovascular Revascularization Medicine. - 2019, vol. 20, no. 7, p. 577–582
English Background: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential improvement in percutaneous coronary intervention (PCI) after the groundbreaking development of drug eluting stents (DES). However, the clinical performance, long-term safety and efficacy of BVS in complex coronary lesions remain uncertain. COMPARE ABSORB, a multicenter, single blind, prospective randomized trial, aims to compare the clinical outcomes between the Absorb BVS and Xience everolimus-eluting metallic stent (EES) in patients with coronary artery disease and a high risk of restenosis.Design: COMPARE ABSORB is designed to enroll 2100 patients at up to 45 European sites. Enrolled patients will possess high risk for restenosis due to clinical profile or coronary lesion complexity and will undergo elective or emergent PCI. Once included in the study, patients will receive either Absorb BVS or Xience EES. Specific advice on implantation technique including mandatory pre-dilatation, sizing and post-dilatation (PSP), will be used in the Absorb BVS arm. The primary endpoint is target lesion failure (TLF), a device-oriented composite endpoint (cardiac death, target vessel myocardial infarction and clinically- indicated target lesion revascularization). The trial is powered to assess non-inferiority of Absorb BVS compared with Xience EES with a predetermined non-inferiority margin of 4.5% at 1 year after index procedure. The clinical follow-up will continue for 7 years.Conclusions: The prospective COMPARE ABSORB randomized trial (ClinicalTrials.gov NCT02486068) will help to assess the long-term safety and efficacy of Absorb BVS compared with Xience EES in the treatments of patients with complex coronary artery disease and a high attendant risk of restenosis.
Faculty
Faculté des sciences et de médecine
Department
Médecine 3ème année
Language
  • English
Classification
Medicine
License
License undefined
Identifiers
Persistent URL
https://folia.unifr.ch/unifr/documents/308166
Other files

Statistics

Document views: 19 File downloads:
  • coo_abs.pdf: 3
  • coo_abs_sm.pdf: 0